Fig. 2.

Potential use of microbiota-targeted therapies for post-stroke recovery. The scheme highlights the potential use of microbiota-targeted therapies such as probiotic therapies as supplementary therapeutic strategies to improve recovery during the chronic phase after stroke. Despite promising preclinical results and first clinical trials, current data is not yet sufficient to prove efficacy of such interventions and to suggest specific compounds or treatment regimens